US Patent 8329639 MUC1 based glycolipopeptide vaccine with adjuvant
Patent 8329639 was granted and assigned to Oncothyreon on December, 2012 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 19, 2012
Date of Patent
December 11, 2012
Patent Application Number
13553061
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8329639 MUC1 based glycolipopeptide vaccine with adjuvant
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.